Bayer debuts contrast media management system
Bayer HealthCare Pharmaceuticals has unveiled plans to launch VistaTrak, a contrast media management system that provides radiology departments with a new management tool to help enhance patient care and safety, optimize inventory management and improve billing accuracy. 

VistaTrak is the result of collaboration between Bayer HealthCare Pharmaceuticals and Mobile Aspects, a provider of radio frequency identification (RFID)-enabled solutions for healthcare and hospital environments. 

The companies worked together to optimize Mobile Aspects’ proprietary iRIS platform for the unique needs and requirements of the radiology environment.  Bayer is the first company to offer a contrast media management system based on an RFID platform to automate manual processes and capture valuable operational data that currently cannot be found in any one system, according to the Pittsburgh-based Mobile Aspects.

VistaTrak combines RFID technology of “tagged” bottles of contrast agent with a “smart” cabinet and a specially designed interface to capture, store and manage product utilization data easily and reliably while helping to reduce the risk of human error.  It provides radiology-specific solutions for the use of contrast media, such as:
  • Facilitating patient safety by automatically screening data from a patient’s electronic medical record (EMR) for, among other things, contraindications and prior adverse events; 
  • Capturing important information stored on the tag, such as NDC number, expiration date and lot number, automatically and in an efficient manner that supports compliance with accrediting organization requirements;
  • Providing accurate contrast dosing information to improve billing accuracy and help address any existing issues with reimbursement or audits; and
  • Tracking inventory to enable departments to order and manage inventory more efficiently and reduce waste.
VistaTrak features an easy-to-use, touch-screen interface and is available in two different sizes to address varying usage needs, according to Bayer.